Juvenescence raises $100M to fund longevity assets to early readouts

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 19, 2019 at 11:22 AM.

  1. #1 cafead, Aug 19, 2019 at 11:22 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Juvenescence has raised $100 million to advance multiple anti-aging programs. The U.K. company, which was co-founded by Jim Mellon, has reeled in $165 million over 18 months to establish itself at the forefront of the nascent longevity sector.

    article source
     
    Quote

Reply to Thread